EUVIMEDEUVIMED entdecken
Crossref

One-year mortality, cardiovascular and limb events in the BEST-CLI Registry of patients with chronic limb-threatening ischemia

E Hope Weissler, Shuang Li, Nishant P Shah, Alik Farber, Matthew Menard, Jennifer A Rymer, W Schuyler Jones, Dennis Narcisse, Vikram S Kashyap, Igor A Laskowski, Carlos Mena Hurtado, Samir K Shah und 6 weitere

Journal of Vascular Surgery · 2026-09

DOI: 10.1016/j.jvs.2026.08.041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2026-09. Verfasst von E Hope Weissler und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Durham, NC. Electron…. Die Arbeit nennt 25 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with chronic limb-threatening ischemia (CLTI) are at risk for cardiovascular events, amputations, hospitalizations, and death. We aimed to describe 1-year outcomes in a broader, nonclinical trial cohort of patients with CLTI at a subset of Best Endovascular vs Best Surgical Therapy for Patients with Critical Limb Ischemia (BEST-CLI) trial sites. METHODS: The BEST-CLI Registry enrolled patients with CLTI from 40 BEST-CLI trial sites between 2019 and 2023. One-year rates of mortality, major adverse limb events (MALE), the composite of mortality or MALE, and major adverse cardiovascular events were reported and compared between key subgroups using multivariable analyses. RESULTS: Of 1009 patients who enrolled in the BEST-CLI Registry, 34.5% were female and 28.1% were Black. Ischemic rest pain was present in 62.8% of patients, and tissue loss in 74.2%. Over the course of a year, 38.9% of patients [95% confidence interval (CI), 35.4%-42.7%] experienced the composite of MALE or mortality; MALE occurred in 17.0% (95% CI, 14.2%-20.4%) and 25.6% died (95% CI, 22.3%-29.1%). Major amputation occurred in 8.2% (95% CI, 6.3%-10.7%) and 20.6% had any revascularization (95% CI, 17.1%-24.8%). Major adverse cardiovascular events occurred in 27.3% of participants (95% CI, 23.9%-30.8%). There were no differences in outcomes between Black and White patients or female and male patients. CONCLUSIONS: In this large, diverse cohort of patients with CLTI, including those ineligible for revascularization, mortality, and limb events were common at 1 year and did not differ based on race or sex. Patients had higher clinical event rates compared with those published in the BEST-CLI trial. Further work is needed to understand the generalizability of BEST-CLI findings to real-world cohorts of patients with CLTI.

Schlagwörter

Stichwörter der Autor:innen

Chronic limb-threatening ischemiaComorbidityPeripheral arterial diseaseProspective studies

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Durham, NC. Electronic address: Hope.weissler@duke.edu.
  • Duke Clinical Research Institute, Durham, NC.
  • Duke Clinical Research Institute, Durham, NC; Division of Cardiology, Duke University School of Medicine, Durham, NC.
  • Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA.
  • The Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Division of Cardiology, Duke University School of Medicine, Durham, NC.

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute

Zitieren

APA

Weissler, E. H., Li, S., Shah, N. P., Farber, A., Menard, M., Rymer, J. A., Jones, W. S., Narcisse, D., Kashyap, V. S., Laskowski, I. A., Hurtado, C. M., Shah, S. K., Dexter, D. J., Strong, M., Rosenfeld, K., Beckman, J., Patel, M., & Vemullapalli, S. (2026). One-year mortality, cardiovascular and limb events in the BEST-CLI Registry of patients with chronic limb-threatening ischemia. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2026.08.041

Vancouver

Weissler EH, Li S, Shah NP, Farber A, Menard M, Rymer JA, et al. One-year mortality, cardiovascular and limb events in the BEST-CLI Registry of patients with chronic limb-threatening ischemia. Journal of Vascular Surgery. 2026. doi:10.1016/j.jvs.2026.08.041

BibTeX
@article{Weissler2026,
  author = {Weissler, E Hope and Li, Shuang and Shah, Nishant P and Farber, Alik and Menard, Matthew and Rymer, Jennifer A and Jones, W Schuyler and Narcisse, Dennis and Kashyap, Vikram S and Laskowski, Igor A and Hurtado, Carlos Mena and Shah, Samir K and Dexter, David J and Strong, Michael and Rosenfeld, Kenneth and Beckman, Joshua and Patel, Manesh and Vemullapalli, Sreekanth},
  title = {One-year mortality, cardiovascular and limb events in the BEST-CLI Registry of patients with chronic limb-threatening ischemia},
  journal = {Journal of Vascular Surgery},
  year = {2026},
  doi = {10.1016/j.jvs.2026.08.041}
}
Kostenlos starten →